Evidence map›Paper›PMID 26016871›Full record

Trial reportMalaria journal2015

Cost-effectiveness of malaria diagnosis using rapid diagnostic tests compared to microscopy or clinical symptoms alone in Afghanistan.

Kristian S Hansen, Eleanor Grieve, Amy Mikhail, Ismail Mayan, Nader Mohammed, Mohammed Anwar, Sayed H Baktash, Thomas L Drake, Christopher J M Whitty, Mark W Rowland and 1 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00935688 (An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species), which is not on this map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00935688 phase4completednot on this map

An Examination of ACT Strategy in South-central Asia on Falciparum Malaria in a Context Where Vivax is the Major Species

TypeinterventionalSponsorLondon School of Hygiene and Tropical MedicineRan2009 to 2010Enrolled4,200ConditionsMalaria, FeverArmsRapid diagnostic test
3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2021
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Epidemiology and Control of Plasmodium vivax in Afghanistan.The American journal of tropical medicine and hygiene · 2016
    Article
  19. Costs and Cost-Effectiveness of Plasmodium vivax Control.The American journal of tropical medicine and hygiene · 2016
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Kristian S HansenDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. kristian.hansen@lshtm.ac.uk.
Eleanor GrieveDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. eleanor.grieve@glasgow.ac.uk.
Amy MikhailDepartment of Disease Control, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. amy.mikhail@gmail.com.
Ismail MayanHealth Protection and Research Organization, Kabul, Afghanistan. drmayan2006@gmail.com.
Nader MohammedHealth Protection and Research Organization, Kabul, Afghanistan. nader.mohammad@googlemail.com.
Mohammed AnwarHealthNet-TPO, Kabul, Afghanistan. dranwarhasanzai@yahoo.com.
Sayed H BaktashMerlin, Kabul, Afghanistan. hbaktash@gmail.com.
Thomas L DrakeDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK. Tom.D@tropmedres.ac.
Christopher J M WhittyDepartment of Clinical Research, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. christopher.whitty@lshtm.ac.uk.
Mark W RowlandDepartment of Disease Control, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. mark.rowland@lshtm.ac.uk.
Toby J LeslieDepartment of Disease Control, London School of Hygiene & Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. toby.leslie1@gmail.com.
London School of Hygiene & Tropical Medicine · GBHealth Protection and Research Organisation · AFUniversity of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImproving access to parasitological diagnosis of malaria is a central strategy for control and elimination of the disease. Malaria rapid diagnostic tests (RDTs) are relatively easy to perform and could be used in primary level clinics to increase coverage of diagnostics and improve treatment of malaria.

methodsA cost-effectiveness analysis was undertaken of RDT-based diagnosis in public health sector facilities in Afghanistan comparing the societal and health sector costs of RDTs versus microscopy and RDTs versus clinical diagnosis in low and moderate transmission areas. The effect measure was 'appropriate treatment for malaria' defined using a reference diagnosis. Effects were obtained from a recent trial of RDTs in 22 public health centres with cost data collected directly from health centres and from patients enrolled in the trial. Decision models were used to compare the cost of RDT diagnosis versus the current diagnostic method in use at the clinic per appropriately treated case (incremental cost-effectiveness ratio, ICER).

resultsRDT diagnosis of Plasmodium vivax and Plasmodium falciparum malaria in patients with uncomplicated febrile illness had higher effectiveness and lower cost compared to microscopy and was cost-effective across the moderate and low transmission settings. RDTs remained cost-effective when microscopy was used for other clinical purposes. In the low transmission setting, RDTs were much more effective than clinical diagnosis (65.2% (212/325) vs 12.5% (40/321)) but at an additional cost (ICER) of US$4.5 per appropriately treated patient including a health sector cost (ICER) of US$2.5 and household cost of US$2.0. Sensitivity analysis, which varied drug costs, indicated that RDTs would remain cost-effective if artemisinin combination therapy was used for treating both P. vivax and P. falciparum. Cost-effectiveness of microscopy relative to RDT is further reduced if the former is used exclusively for malaria diagnosis. In the health service setting of Afghanistan, RDTs are a cost-effective intervention compared to microscopy.

conclusionsRDTs remain cost-effective across a range of drug costs and if microscopy is used for a range of diagnostic services. RDTs have significant advantages over clinical diagnosis with minor increases in the cost of service provision.

trial registrationThe trial was registered at ClinicalTrials.gov under identifier NCT00935688.

Indexed as

Cost-Benefit AnalysisAdolescentAdultAfghanistanAgedAnimalsAntimalarialsArtemisininsChildChild, PreschoolDiagnostic Tests, RoutineDrug CombinationsHumansInfantMalaria, FalciparumMalaria, VivaxAntimalarialsartemisininArtemisininsDrug Combinations

Identifiers

PMID26016871
PMCPMC4450447
OpenAlexW2134061730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.